-
1
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies
Published 2024-12-01Get full text
Article -
2
-
3
-
4
-
5
-
6
-
7
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG1 antibody
Published 2024-12-01Get full text
Article -
8
Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations
Published 2024-12-01Get full text
Article -
9
Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening
Published 2025-01-01Get full text
Article -
10
-
11
-
12
-
13
-
14
Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
Published 2017-01-01Get full text
Article -
15
-
16
Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies
Published 2016-01-01Get full text
Article -
17
Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children
Published 2018-01-01“…To report the efficacy of subconjunctival triamcinolone (Kenalog A-40, Alcon) and bevacizumab (Avastin, Genentech) injections in fraternal twins with blepharokeratoconjunctivitis (BKC) causing progressive, bilateral corneal neovascularization and scarring. …”
Get full text
Article -
18
-
19
A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline
Published 2014-07-01Get full text
Article -
20
Engineered ipilimumab variants that bind human and mouse CTLA-4
Published 2025-12-01Get full text
Article